Literature DB >> 25081927

Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study.

Lei-Ming Sun1, Kuo-Hsien Wang, Yuan-Chii G Lee.   

Abstract

Keloids is a fibroproliferative disease. The incidence of keloids among Asians has not been thoroughly studied. The objective of this study is to determine the incidence of keloids in Taiwan, which mainly consists of ethnic Chinese. Furthermore, we want to determine the comorbidity rate of other fibrosis-related diseases among keloid patients. This study was based on the National Health Insurance Research Database, which contains the data of 1 million randomly selected patients. Multivariate logistic regression analyses were employed to estimate the relative odds of keloids as a function of fibrosis-related diseases. The annual keloid incidence rate in Taiwan was 0.15 % for the general population. With a 1.33 ratio, women outnumbered men. Women with uterine leiomyoma have a 2.25-fold greater risk of keloids, compared with women without leiomyoma. We concluded that keloid incidence in Taiwan is approximately 0.15 %. Women with leiomyoma have a greater risk of keloids, this implicates that both diseases share a common etiopathological pathway.

Entities:  

Mesh:

Year:  2014        PMID: 25081927     DOI: 10.1007/s00403-014-1491-5

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

1.  SNP rs1511412 in FOXL2 gene as a risk factor for keloid by meta analysis.

Authors:  Wensheng Lu; Xiaodong Zheng; Shengli Liu; Maoqian Ding; Jian Xie; Xiuhua Yao; Lanfang Zhang; Bai Hu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Genomic risk variants at 3q22.3 are associated with keloids in a Chinese Han population.

Authors:  Meng-Zhu Lu; Qian-Qian Ang; Xiang Zhang; Lan-Fang Zhang; Xiu-Hua Yao; Hong Lv; Xiao-Dong Zheng; Wen-Sheng Lu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

3.  A prospective, randomized assessment of a novel, local antibiotic releasing platform for the prevention of superficial and deep surgical site infections.

Authors:  O Zmora; Y Stark; O Belotserkovsky; M Reichert; G A Kozloski; N Wasserberg; H Tulchinsky; L Segev; A J Senagore; N Emanuel
Journal:  Tech Coloproctol       Date:  2022-09-01       Impact factor: 3.699

Review 4.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 5.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

Review 6.  Current Advances in Hypertrophic Scar and Keloid Management.

Authors:  Natasha Barone; Tyler Safran; Joshua Vorstenbosch; Peter G Davison; Sabrina Cugno; Amanda M Murphy
Journal:  Semin Plast Surg       Date:  2021-07-15       Impact factor: 2.195

7.  Time Heals all Wounds- but Scars Remain. Can Personalized Medicine Help?

Authors:  Saeid Amini-Nik
Journal:  Front Genet       Date:  2018-06-22       Impact factor: 4.599

Review 8.  Finding Solutions for Fibrosis: Understanding the Innate Mechanisms Used by Super-Regenerator Vertebrates to Combat Scarring.

Authors:  Fallon Durant; Jessica L Whited
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

9.  Long non-coding RNA CACNA1G-AS1 promotes calcium channel protein expression and positively affects human keloid fibroblast migration.

Authors:  Ye Li; Xuebing Liang; Peng Wang; Xiao Long; Xiaojun Wang; Zhiqiang Meng
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

10.  Aging Suppresses Skin-Derived Circulating SDF1 to Promote Full-Thickness Tissue Regeneration.

Authors:  Mailyn A Nishiguchi; Casey A Spencer; Denis H Leung; Thomas H Leung
Journal:  Cell Rep       Date:  2018-09-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.